Risk of menopause during the first year after breast cancer diagnosis
- PMID: 10561298
- DOI: 10.1200/JCO.1999.17.8.2365
Risk of menopause during the first year after breast cancer diagnosis
Abstract
Purpose: Premenopausal women with breast cancer often enter a premature menopause during initial treatment of their malignancy, with resulting loss of childbearing capacity, onset of menopausal symptoms, and subsequent prolonged exposure to long-term risks of menopause. Adjuvant therapy is believed to contribute to this early menopause.
Patients and methods: One hundred eighty-three premenopausal women with locoregional breast cancer (tumor-node-metastasis staging system classification, T1-3 N0-1 M0) who had undergone surgical treatment and provided information on menopausal status at diagnosis and 1 year later were enrolled. Systemic adjuvant therapy was recorded. Univariate and multivariate predictors of menopause were examined.
Results: Age, weight gain, tumor stage, nodal stage, and systemic adjuvant therapy (chemotherapy, tamoxifen) were all significant univariate correlates of menopause. In multivariate analysis, age, chemotherapy, and hormone therapy (tamoxifen) made significant independent contributions to the onset of menopause.
Conclusion: Age and systemic chemotherapy are the strongest predictors of menopause in women with locoregional breast cancer. They independently contribute to menopause. A graphic representation of our multivariate model allows an estimation of risk of menopause according to patient age and planned adjuvant treatment, and it may facilitate clinical decision-making.
Similar articles
-
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678. Cancer. 2002. PMID: 12124820 Clinical Trial.
-
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.Clin Cancer Res. 1995 Feb;1(2):189-98. Clin Cancer Res. 1995. PMID: 9815973
-
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.JAMA. 2011 Jul 20;306(3):269-76. doi: 10.1001/jama.2011.991. JAMA. 2011. PMID: 21771987 Clinical Trial.
-
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.Oncology (Williston Park). 2009 Jan;23(1):27-33. Oncology (Williston Park). 2009. PMID: 19283918 Review.
-
Adjuvant chemotherapy in early breast cancer.Dan Med J. 2016 May;63(5):B5222. Dan Med J. 2016. PMID: 27127018 Review.
Cited by
-
Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?Breast Cancer. 2021 Nov;28(6):1243-1251. doi: 10.1007/s12282-021-01260-x. Epub 2021 May 11. Breast Cancer. 2021. PMID: 33974201
-
Developing a self-administered questionnaire as a guide to consultations with women treated for breast cancer.Int J Family Med. 2011;2011:390692. doi: 10.1155/2011/390692. Epub 2011 May 23. Int J Family Med. 2011. PMID: 22295185 Free PMC article.
-
GnRH agonist therapy to protect ovarian function in young Korean breast cancer patients.J Korean Med Sci. 2010 Jan;25(1):110-6. doi: 10.3346/jkms.2010.25.1.110. Epub 2009 Dec 26. J Korean Med Sci. 2010. PMID: 20054409 Free PMC article. Clinical Trial.
-
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.Drug Saf. 2005;28(12):1085-100. doi: 10.2165/00002018-200528120-00004. Drug Saf. 2005. PMID: 16329712 Review.
-
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer.Cancer Manag Res. 2019 May 8;11:4273-4282. doi: 10.2147/CMAR.S204069. eCollection 2019. Cancer Manag Res. 2019. PMID: 31190993 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical